Sign In
Buy OCGN
$1.22
+0.0100 (+0.83%)
At Close: Jun 15, 2026
NEW ORLEANS, Sept. 24, 2021 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C.
Is Ocugen Worth Another Look After Good News for COVID Vaccine Covaxin?
06:14am, Friday, 24'th Sep 2021
An anticipated emergency use listing for the vaccine won't help Ocugen.
Ocugen, Inc. to Participate in Fireside Chat at the Cantor Virtual Global Healthcare Conference
04:08pm, Thursday, 23'rd Sep 2021
MALVERN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc . (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness dis
Ocugen's India-Based Partner Concludes COVID-19 Vaccine Trials In Children: Report
08:04am, Tuesday, 21'st Sep 2021
India-based Bharat Biotech has completed the Phase 2 and 3 trials of COVID-19 vaccine, Covaxin, for use in 2 to 18 years. Ocugen Inc (NASDAQ: OCGN) is the U.S. partner for the vaccine.
It's OK to Sell the News on Ocugen and Covaxin
06:00am, Monday, 20'th Sep 2021
OCGN stock jumped when Covaxin received WHO approval. But with two major obstacles in the way of U,S.
Could This News Spark a Turnaround for Ocugen?
06:00am, Sunday, 19'th Sep 2021
Ocugen shares soared more than 700% early in the year. They've since lost half of the gain.
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:52pm, Friday, 17'th Sep 2021
MALVERN, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness dise
Why COVID Vaccine Stocks BioNTech, Moderna, and Novavax Are Sliding While Ocugen Is Rising
11:17am, Friday, 17'th Sep 2021
Investors are nervous about a Food and Drug Administration advisory panel meeting and optimistic about a World Health Organization decision.
WHO Approval Should Get Ocugen Stock Over the $15 Barrier
05:21pm, Thursday, 16'th Sep 2021
Sharp up-and-down moves in OCGN stock shouldn't scare investors away, as a regulator's nod for Covaxin should put the stock back on track. The post WHO Approval Should Get Ocugen Stock Over the $15 Ba
Do Options Traders Know Something About Ocugen (OCGN) Stock We Don't?
09:56am, Wednesday, 15'th Sep 2021
Investors need to pay close attention to Ocugen (OCGN) stock based on the movements in the options market lately.
Here's What the Charts Say About Ocugen Stock Now
06:00am, Wednesday, 15'th Sep 2021
Ocugen is a high-risk, high-reward speculative play. The charts for OCGN stock show some promise, but here's the level it has to hold above.
OCGN Stock: Why Ocugen Shares Are Shooting Higher Today
05:07pm, Monday, 13'th Sep 2021
The WHO could be about to green light a vaccine from one of Ocugen's partners, but that doesn't mean OCGN stock will stay in the green. The post OCGN Stock: Why Ocugen Shares Are Shooting Higher Today
Where's Ocugen Stock Headed Monday And Why?
03:05pm, Monday, 13'th Sep 2021
Ocugen Inc. (NASDAQ: OCGN) shares were trading higher Monday, after Bharat Biotech: a company partner, was given the nod for a COVID-19 vaccine by the World Health Organization. The company saw a larg
Here's Why Ocugen Is Skyrocketing Today
02:10pm, Monday, 13'th Sep 2021
There's both good and bad news for this troubled coronavirus vaccine biotech.
OCGN Stock: What Ocugen Investors Are Saying as Shares Surge Today
01:06pm, Monday, 13'th Sep 2021
Ocugen (OCGN) stock is on the move today as traders on social media push the company higher in a new rally for the shares. The post OCGN Stock: What Ocugen Investors Are Saying as Shares Surge Today a
